Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guidelineDawn L Hershman, Christina Lacchetti, Robert H Dworkin, et al.Journal for Immunotherapy of Cancer|November 14, 2024
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse eventsMalek Shatila, Hao Chi Zhang, Anusha Shirwaikar Thomas, et al.Expert Opinion on Drug Safety|February 10, 2026
Rare irAes associated with immune checkpoint inhibitor therapyJarrett Rong, Faraz Jafri, Sean Ngo, et al.JACC. Cardiooncology|January 13, 2023
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced MyocarditisAlexi Vasbinder, YeeAnn Chen, Adrien Procureur, et al.NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M Tolaney, Nabihah Tayob, Chau Dang, et al.NPJ Breast Cancer|February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trialRomualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.Research Square|June 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncologyMichelle Churchman, Xin Lu, David McKean, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPTPaolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.Pageof 4